Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00036127 |
Recruitment Status
:
Completed
First Posted
: May 9, 2002
Last Update Posted
: November 11, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Schizophrenia | Drug: aripiprazole | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Primary Purpose: | Treatment |
Study Start Date : | April 2002 |
Actual Primary Completion Date : | January 2003 |
Actual Study Completion Date : | January 2003 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Agitated schizophrenic patients

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00036127
United States, California | |
Local Institution | |
Anaheim, California, United States | |
Local Institution | |
Cerritos, California, United States | |
Local Institution | |
Chula Vista, California, United States | |
Local Institution | |
Rosemead, California, United States | |
Local Institution | |
San Diego, California, United States | |
United States, Georgia | |
Local Institution | |
Atlanta, Georgia, United States | |
Local Institution | |
Macon, Georgia, United States | |
United States, Illinois | |
Local Instituton | |
Hoffman Estates, Illinois, United States | |
United States, Nevada | |
Local Institution | |
Las Vegas, Nevada, United States | |
United States, New Hampshire | |
Local Institution | |
Nashua, New Hampshire, United States | |
United States, New York | |
Local Institution | |
New York, New York, United States | |
United States, Ohio | |
Local Institution | |
Beachwood, Ohio, United States | |
United States, Pennsylvania | |
Local Institution | |
Philadelphia, Pennsylvania, United States | |
United States, South Carolina | |
Local Institution | |
Charleston, South Carolina, United States | |
United States, Texas | |
Local Institution | |
Houston, Texas, United States | |
United States, Wisconsin | |
Local Institution | |
Milwaukee, Wisconsin, United States |
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: | NCT00036127 History of Changes |
Other Study ID Numbers: |
CN138-050 |
First Posted: | May 9, 2002 Key Record Dates |
Last Update Posted: | November 11, 2013 |
Last Verified: | September 2007 |
Keywords provided by Otsuka Pharmaceutical Development & Commercialization, Inc.:
agitated schizophrenic patients |
Additional relevant MeSH terms:
Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders Aripiprazole Antipsychotic Agents |
Tranquilizing Agents Central Nervous System Depressants Physiological Effects of Drugs Psychotropic Drugs |